These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Alternative splicing products of the tenascin gene distinguish rat liver fat storing cells from arterial smooth muscle cells and skin fibroblasts.
    Author: Schwögler S, Odenthal M, Meyer zum Büschenfelde KH, Ramadori G.
    Journal: Biochem Biophys Res Commun; 1992 Jun 15; 185(2):768-75. PubMed ID: 1376992.
    Abstract:
    Fat storing-(Ito-)cells (FSC) transform into a myofibroblast-like cell type during liver fibrogenesis. A similar development can be observed in cell culture. At the moment, a definite marker to differentiate transformed FSC from smooth muscle cells (SMC) is not available. We recently found that FSC, SMC and skin fibroblasts (SF) synthesize tenascin, a novel matrix protein. As it is reported that various tissues express different tenascin forms by the mechanism of alternative pre-mRNA splicing, we analyzed the tenascin transcripts in these cell types. Total RNA extracted from cultured FSC, SMC and SF, analyzed by Northern blot hybridization, showed a 7.2 kb transcript in FSC, a 8.7 kb mRNA in SMC, whereas SF produced both messages. As the splicing pattern of FSC in primary culture did not change after passaging, this differential expression of tenascin mRNA might provide a tool to identify myofibroblast-like cells derived from FSC. The important fibrogenic mediator transforming growth factor-beta (TGF-beta) increased tenascin gene expression in each cell type. In SMC, TGF-beta additionally induced the production of the 7.2 kb transcript. Determination of tenascin transcripts will allow to examine the purity of FSC cultures and facilitate a better identification of the cells involved in liver fibrosis.
    [Abstract] [Full Text] [Related] [New Search]